Marrone Bio Innovations restates financial statements and files reports for 2014 and first two quarters of 2015
Davis, California, USA
November 10, 2015
Marrone Bio Innovations, Inc. (the "Company") (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the completion of its restatement and the filing of its 2014 Annual Report on Form 10-K and first and second quarter 2015 Quarterly Reports on Form 10-Q. More detail related to the restatement and the Company's financial results for 2014 and the first half of 2015 is available in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC").
The Company currently expects to timely file its third quarter 2015 results, but until the Quarterly Report on Form 10-Q for such period has been filed, the Company will not be in a position to further comment on the restatement or its other results of operations.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe.
More news from: Marrone Bio Innovations
Website: http://marronebioinnovations.com/ Published: November 10, 2015 |
The news item on this page is copyright by the organization where it originated Fair use notice |